Introduction
Cyanosis is defined as a bluish or grey discoloration of the skin, lips, nail beds, or mucous membranes due to increased amounts of deoxygenated hemoglobin (>5 g/dL) in capillary blood or abnormal hemoglobin variants.
It is an important clinical sign, often pointing to underlying cardiac, pulmonary, vascular, or hematological disease.
Types of Cyanosis
-
Central Cyanosis
-
Generalized bluish discoloration (lips, tongue, mucous membranes, skin).
-
Indicates systemic hypoxemia (low oxygen in arterial blood).
-
Causes: lung disease, heart disease, high altitude.
-
-
Peripheral Cyanosis
-
Affects extremities (fingers, toes, nail beds) but lips/tongue may remain pink.
-
Due to reduced blood flow or increased oxygen extraction.
-
Causes: cold exposure, shock, peripheral vascular disease, heart failure.
-
-
Differential Cyanosis
-
Bluish lower limbs but not upper limbs (seen in patent ductus arteriosus with pulmonary hypertension).
-
-
Pseudocyanosis
-
Bluish skin due to drugs (amiodarone, chloroquine) or metals (silver, gold), not due to hypoxemia.
-
Pathophysiology
-
Cyanosis develops when deoxygenated hemoglobin rises above 5 g/dL in capillary blood.
-
In anemia (low hemoglobin), cyanosis may be absent despite hypoxemia.
-
In polycythemia (high hemoglobin), cyanosis may appear even with mild hypoxemia.
-
Abnormal hemoglobin forms (methemoglobin, sulfhemoglobin) can also cause cyanosis.
Causes of Cyanosis
1. Respiratory Causes (Impaired Oxygenation)
-
Chronic obstructive pulmonary disease (COPD).
-
Asthma exacerbation.
-
Pneumonia.
-
Pulmonary embolism.
-
Interstitial lung disease.
-
Acute respiratory distress syndrome (ARDS).
-
High altitude.
2. Cardiac Causes (Right-to-Left Shunts / Poor Circulation)
-
Congenital heart disease (Tetralogy of Fallot, Eisenmenger syndrome).
-
Heart failure.
-
Myocardial infarction with low output.
-
Severe arrhythmias.
3. Hematological / Abnormal Hemoglobin
-
Methemoglobinemia (caused by drugs: dapsone, nitrates, benzocaine).
-
Sulfhemoglobinemia (rare, caused by sulfonamides).
-
Severe polycythemia.
4. Vascular / Peripheral
-
Shock, circulatory collapse.
-
Peripheral vascular disease.
-
Raynaud’s phenomenon.
-
Cold exposure.
5. Other / Rare
-
Sepsis.
-
Poisoning (carbon monoxide → “cherry red” but can mimic cyanosis).
Clinical Features
-
Skin/lips/mucous membranes: Blue, grey, or dusky color.
-
Central cyanosis: Lips, tongue, conjunctiva involved.
-
Peripheral cyanosis: Hands, feet, fingers, toes affected.
-
Associated symptoms depend on cause:
-
Shortness of breath, cough, wheezing (respiratory).
-
Chest pain, palpitations, edema (cardiac).
-
Cold extremities, pain, ulcers (vascular).
-
Headache, dizziness, confusion (methemoglobinemia, hypoxemia).
-
Diagnostic Approach
1. History
-
Onset: acute (PE, asthma, MI) vs chronic (COPD, heart disease).
-
Triggers: cold, exercise, altitude.
-
Medications: nitrates, dapsone, anesthetics.
-
Family history of congenital heart disease.
2. Examination
-
Distribution: central vs peripheral.
-
Vital signs: oxygen saturation, BP, HR, temperature.
-
Respiratory exam: wheeze, crackles.
-
Cardiac exam: murmurs, heart failure signs.
-
Extremities: pulses, skin temperature, capillary refill.
3. Investigations
-
Pulse oximetry: O₂ saturation <85% → cyanosis likely.
-
Arterial blood gas (ABG): PaO₂ <60 mmHg in hypoxemia.
-
Co-oximetry: Detects methemoglobin, carboxyhemoglobin.
-
Chest X-ray: Pneumonia, heart failure, effusion.
-
ECG & Echocardiography: Heart disease, shunts, pulmonary hypertension.
-
CT angiography: Pulmonary embolism.
-
Blood tests: CBC (polycythemia, anemia), renal/liver function.
Management and Treatment
Principle: Cyanosis is a sign → always treat underlying cause.
A. General Emergency Measures
-
Oxygen therapy: Nasal cannula (2–6 L/min) or mask.
-
Airway support if severe (intubation, mechanical ventilation).
B. Respiratory Causes
-
Asthma/COPD:
-
Oxygen, inhaled salbutamol 100–200 mcg every 4–6 h PRN.
-
Ipratropium 20 mcg inhaled every 6 h.
-
Prednisone 40 mg orally daily × 5–7 days.
-
-
Pneumonia:
-
Amoxicillin 1 g orally three times daily × 5–7 days.
-
Severe: Ceftriaxone 1–2 g IV daily + Azithromycin 500 mg IV/orally daily.
-
-
Pulmonary embolism:
-
Oxygen, anticoagulation.
-
Enoxaparin 1 mg/kg SC every 12 h.
-
Oral option: Apixaban 10 mg orally twice daily × 7 days, then 5 mg BID.
-
C. Cardiac Causes
-
Heart failure:
-
Furosemide 20–40 mg IV for fluid overload.
-
Enalapril 2.5–10 mg orally twice daily.
-
Carvedilol 3.125–25 mg orally twice daily.
-
-
Acute MI:
-
Oxygen, nitrates, aspirin 325 mg chewed, morphine, PCI if available.
-
-
Congenital cyanotic heart disease: Surgical correction or palliative shunt procedures.
D. Hematological / Toxic Causes
-
Methemoglobinemia:
-
Methylene blue 1–2 mg/kg IV over 5 min.
-
-
Sulfhemoglobinemia: Supportive, stop causative drug.
-
Polycythemia: Venesection (phlebotomy).
E. Peripheral / Vascular Causes
-
Shock: IV fluids, vasopressors (norepinephrine infusion).
-
Peripheral arterial disease: Antiplatelets (Aspirin 75–150 mg daily), statins, revascularization if severe.
-
Raynaud’s: Nifedipine 10–30 mg orally three times daily.
-
Cold exposure: Gradual warming, remove wet clothes.
Complications
-
Hypoxic brain injury.
-
Arrhythmias, cardiac arrest.
-
Cor pulmonale in chronic lung disease.
-
Secondary polycythemia (chronic hypoxemia).
-
Severe psychological distress.
Prognosis
-
Acute reversible causes (asthma, pneumonia, PE): Good if treated early.
-
Chronic diseases (COPD, cyanotic heart disease): Variable, depends on severity.
-
Toxic causes (methemoglobinemia): Rapid recovery if treated promptly.
Patient Education
-
Cyanosis is a warning sign → seek urgent medical help.
-
Stop smoking, avoid pollutants.
-
Manage chronic diseases (COPD, heart failure, diabetes).
-
Stay warm in cold environments to avoid peripheral cyanosis.
-
Patients with congenital heart disease require lifelong follow-up.
No comments:
Post a Comment